These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Current clinical applications of botulinum toxin. Truong DD; Stenner A; Reichel G Curr Pharm Des; 2009; 15(31):3671-80. PubMed ID: 19925419 [TBL] [Abstract][Full Text] [Related]
6. On muscle spindles, dystonia and botulinum toxin. Rosales RL; Dressler D Eur J Neurol; 2010 Jul; 17 Suppl 1():71-80. PubMed ID: 20590812 [TBL] [Abstract][Full Text] [Related]
7. [Mode of action and effects of botulinum neurotoxin A]. Périé S; Lacau St-Guily J Ann Otolaryngol Chir Cervicofac; 1996; 113(2):73-8. PubMed ID: 8999747 [TBL] [Abstract][Full Text] [Related]
8. Change of stretch reflex threshold in spasticity: effect of botulinum toxin injections. Stampacchia G; Bradaschia E; Rossi B Arch Ital Biol; 2004 May; 142(3):265-73. PubMed ID: 15260380 [TBL] [Abstract][Full Text] [Related]
9. Physiological effects of botulinum toxin in spasticity. Gracies JM Mov Disord; 2004 Mar; 19 Suppl 8():S120-8. PubMed ID: 15027064 [TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin for treatment of dystonia. Dressler D Eur J Neurol; 2010 Jul; 17 Suppl 1():88-96. PubMed ID: 20590814 [TBL] [Abstract][Full Text] [Related]
11. Injectable neuromuscular blockade in the treatment of spasticity and movement disorders. Tilton AH J Child Neurol; 2003 Sep; 18 Suppl 1():S50-66. PubMed ID: 13677571 [TBL] [Abstract][Full Text] [Related]
12. Long-term treatment outcome with different formulations of botulinum toxin. Pérez-Saldaña MT; Tan EK; Burguera JA Eur J Neurol; 2009 Mar; 16(3):285-6. PubMed ID: 19364359 [No Abstract] [Full Text] [Related]
13. Possible mechanisms for the effects of botulinum toxin on pain. Arezzo JC Clin J Pain; 2002; 18(6 Suppl):S125-32. PubMed ID: 12569959 [TBL] [Abstract][Full Text] [Related]
14. Neurophysiological changes induced by the botulinum toxin type A injection in children with cerebral palsy. Frascarelli F; Di Rosa G; Bisozzi E; Castelli E; Santilli V Eur J Paediatr Neurol; 2011 Jan; 15(1):59-64. PubMed ID: 20493744 [TBL] [Abstract][Full Text] [Related]
15. Movement, visceral and autonomic disorders: use of botulinum toxin. Moore AP Hosp Med; 2003 Aug; 64(8):452-9. PubMed ID: 12958755 [TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin: a deadly substance with great therapeutic effect. Holmes S Prof Nurse; 2003 Oct; 19(2):85-7. PubMed ID: 14593781 [TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin for pain. Casale R; Tugnoli V Drugs R D; 2008; 9(1):11-27. PubMed ID: 18095750 [TBL] [Abstract][Full Text] [Related]
18. Physiological effects produced by botulinum toxin treatment of upper limb dystonia. Changes in reciprocal inhibition between forearm muscles. Priori A; Berardelli A; Mercuri B; Manfredi M Brain; 1995 Jun; 118 ( Pt 3)():801-7. PubMed ID: 7600096 [TBL] [Abstract][Full Text] [Related]
19. Clinical presentation and management of antibody-induced failure of botulinum toxin therapy. Dressler D Mov Disord; 2004 Mar; 19 Suppl 8():S92-S100. PubMed ID: 15027060 [TBL] [Abstract][Full Text] [Related]
20. Xeomin: an innovative new botulinum toxin type A. Frevert J Eur J Neurol; 2009 Dec; 16 Suppl 2():11-3. PubMed ID: 20002741 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]